These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1079637)

  • 21. Effect of urokinase on fibrinolysis and fibrinogenolysis.
    Matsuo O; Nishida Y; Akazawa K; Mihara H
    Jpn J Physiol; 1982; 32(5):879-83. PubMed ID: 6759739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subunits and susceptibility of fibrins formed from bovine fibrinogen by arvin, reptilase, thrombin and staphylothrombin.
    Zajdel M; Wegrzynowicz Z; Sawecka J; Kopeć M
    Thromb Res; 1975 Apr; 6(4):337-44. PubMed ID: 1169826
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator.
    Westlund LE; Lundén R; Wallén P
    Haemostasis; 1982; 11(4):235-41. PubMed ID: 6982199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
    Andrew M; Brooker L; Leaker M; Paes B; Weitz J
    Thromb Haemost; 1992 Sep; 68(3):325-30. PubMed ID: 1440499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the binding of native plasminogen to fibrin and its role in thrombolysis.
    Shah GA; Dhall DP
    Thromb Res; 1983 Oct; 32(1):67-72. PubMed ID: 6658707
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor.
    Aoki N; Sakata Y; Matsuda M; Tateno K
    Blood; 1980 Mar; 55(3):483-8. PubMed ID: 7357079
    [No Abstract]   [Full Text] [Related]  

  • 28. The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards.
    Brommer EJ
    Thromb Res; 1984 Apr; 34(2):109-15. PubMed ID: 6539513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
    Takada A; Takada Y
    Thromb Res; 1982 Feb; 25(3):229-35. PubMed ID: 7038978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.
    Takada A; Urano T; Takada Y
    Thromb Haemost; 1979 Oct; 42(3):901-8. PubMed ID: 505405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of efficacy of thrombolysin, streptokinase, and urokinase in a femoral vein clot model in rats.
    Cooley BC; Jones MM; Dellon AL
    Microsurgery; 1983; 4(1):1-4. PubMed ID: 6226846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of urokinase on growth and metastases of rabbit V2 carcinoma.
    Kodama Y; Tanaka K
    Gan; 1978 Feb; 69(1):9-18. PubMed ID: 640328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Threshold phenomena in blood fibrinolysis.
    Matsuo O; Mihara H
    Thromb Res; 1977 May; 10(5):753-8. PubMed ID: 882961
    [No Abstract]   [Full Text] [Related]  

  • 37. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
    Thorsen S
    Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
    [No Abstract]   [Full Text] [Related]  

  • 38. Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen.
    Takada Y; Makino Y; Takada A
    Thromb Res; 1985 Aug; 39(3):289-96. PubMed ID: 4049320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of a sustained fibrinolytic response by BRL 26921 in vitro.
    Fears R; Green J; Smith RA; Walker P
    Thromb Res; 1985 May; 38(3):251-60. PubMed ID: 3895561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.